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ABSTRACT: Positioned at the C-terminus of many eukaryotic proteins, the glycosylphosphatidylinositol
(GPI) anchor is a posttranslational modiﬁcation that anchors the modiﬁed protein in the outer leaﬂet of
the cell membrane. The GPI anchor is a complex structure comprising a phosphoethanolamine linker,
glycan core, and phospholipid tail. GPI-anchored proteins are structurally and functionally diverse and
play vital roles in numerous biological processes. While several GPI-anchored proteins have been
characterized, the biological functions of the GPI anchor have yet to be elucidated at a molecular level.
This review discusses the structural diversity of the GPI anchor and its putative cellular functions, including
involvement in lipid raft partitioning, signal transduction, targeting to the apical membrane, and prion
disease pathogenesis. We speciﬁcally highlight studies in which chemically synthesized GPI anchors and
analogues have been employed to study the roles of this unique posttranslational modiﬁcation.
First characterized approximately 20 years ago, the gly-
cosylphosphatidylinositol (GPI
1) anchor is a glycolipid
structure that is added posttranslationally to the C-terminus
of many eukaryotic proteins (1–6). This modiﬁcation anchors
the attached protein in the outer leaﬂet of the cell
membrane (3, 7, 8). Proteins containing a GPI anchor are
functionally diverse and play important roles in signal
transduction, prion disease pathogenesis, immune response,
and the pathobiology of trypanosomal parasites (1, 9). Unlike
simple lipid modiﬁcations, the GPI anchor has a complex
structure that includes a phosphoethanolamine linker, glycan
core, and phospholipid tail (Figure 1) (1, 2). The phospho-
inositol, glucosamine, and mannose residues within the
glycan core can be variously modiﬁed with phosphoetha-
nolamine groups and other sugars (1, 2). Such structural
complexity would be expected to encode diverse functional
capacity beyond membrane insertion. However, deﬁnitive
conclusions that relate GPI anchor structure and function
have been difﬁcult to draw. While many GPI-anchored
proteins have been identiﬁed and characterized, the only
conﬁrmed biological function of the GPI anchor is to provide
the protein with a stable membrane anchoring device
(2, 10, 11). Several excellent reviews have discussed the
† This work was supported by National Institutes of Health Grant
GM59907 (to C.R.B.) and a Howard Hughes Medical Institute
predoctoral fellowship (to M.G.P.).
* To whom correspondence should be addressed. E-mail: crb@
berkeley.edu. Phone: (510) 643-1682. Fax: (510) 643-2628.
‡ Department of Chemistry, University of California, Berkeley.
§ Department of Molecular and Cell Biology, University of Cali-
fornia, Berkeley.
| Howard Hughes Medical Institute, University of California,
Berkeley.
⊥ The Molecular Foundry, Lawrence Berkeley National Laboratory.
# Physical Biosciences and Materials Sciences Divisions, Lawrence
Berkeley National Laboratory.
1 Abbreviations: AChE, acetylcholinesterase; APase, alkaline phos-
phatase; DAF, decay-accelerating factor; FRET, ﬂuorescence resonance
energy transfer; Gal, galactose; GalNAc, N-acetylgalactosamine; GFP,
green ﬂuorescent protein; GFP-GPI, GPI-anchored green ﬂuorescent
protein, GH-GPI, GPI-anchored growth hormone; GPI, glycosylphos-
phatidylinositol; HexNAc, N-acetylhexosamine; PI-PLC, phosphati-
dylinositol phospholipase C; Man, mannose; NANA, sialic acid;
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FIGURE 1: Structure of the GPI anchor from human erythrocyte
acetylcholinesterase (16). The three domains of the GPI anchor are
(i) a phosphoethanolamine linker (red), (ii) the conserved glycan
core (black), and (iii) a phospholipid tail (blue). Appendages in
blue (including the lipids of the lipid tail) are variable.
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the biosynthesis of the GPI anchor and its transfer to
proteins (3, 7, 8, 12–15). In this review, we will focus on
the structure of the GPI anchor and its biological functions
in mammalian cells. The putative roles of the GPI anchor in
lipid raft partitioning, signal transduction, cellular com-
munication, apical membrane targeting, and prion disease
pathogenesis will be discussed. Particular attention will be
given to recent studies that attempt to more thoroughly deﬁne
the functional signiﬁcance of the GPI anchor using chemi-
cally synthesized GPI anchors and GPI anchor analogues.
DISCOVERY OF THE GPI ANCHOR
In 1976, a novel phospholipase that acts upon phosphati-
dylinositol was puriﬁed from Bacillus cereus. This phos-
pholipase, termed phosphatidylinositol phospholipase C (PI-
PLC), was found to release alkaline phosphatase (APase)
from tissues. Over the next several years, PI-PLCs puriﬁed
from other types of bacteria (such as Staphylococcus aureus
and Clostridium noVyi) also were found to contain similar
enzymatic activity. Additionally, various other proteins, such
as 5′-nucleotidase and erythrocyte acetylcholinesterase (AChE),
were released from tissues when treated with PI-PLC. Based
on this evidence, these proteins were suggested to be
covalently attached to the cell membrane via a site on the
protein and a phosphatidylinositol molecule embedded in the
lipid bilayer (reviewed in ref 17).
By 1985, the structural components of the C-termini of
two cell surface proteins, variant surface glycoprotein (VSG),
found on the parasitic protozoan Trypanosoma brucei, and
Thy-1, a glycoprotein expressed on mammalian thymocytes
and the brain, had been identiﬁed. The C-terminus of VSG
contained (i) an ethanolamine amide-linked to the C-terminal
amino acid, (ii) a polysaccharide consisting of mannose,
glucosamine, and variable amounts of galactose, and (iii) a
phospholipid that could be degraded by bacterial PI-PLC to
give 1,2-dimyristylglycerol. The C-terminal cysteine of Thy-1
was attached to a structure that contained ethanolamine,
glucosamine, galactosamine, mannose, myo-inositol, phos-
phate, glycerol, and stearic acid. This structural information
was combined with data from PI-PLC studies to establish a
general structure for the GPI membrane anchor (reviewed
in refs 3 and 17).
STRUCTURE OF THE GPI ANCHOR
Although the general components of the GPI anchor had
been identiﬁed, the ﬁrst detailed structural analysis of a GPI
anchor was not completed until 1988. Ferguson and co-
workers determined the exact structure of the VSG anchor
from T. brucei through a combination of NMR spectroscopy,
mass spectrometry, chemical modiﬁcation, and exoglycosi-
dase digestions (4). As a result of this and other investiga-
tions, a general pattern for the GPI anchor structure has
emerged (1, 2).
The C-terminus of a GPI-anchored protein is linked
through a phosphoethanolamine bridge to the highly con-
served core glycan, mannose(R1-2)mannose(R1-6)man-
nose(R1-4)glucosamine(R1-6)myo-inositol (Figure 1). A
phospholipid tail attaches the GPI anchor to the cell
membrane. The glycan core can be variously modiﬁed with
side chains, such as a phosphoethanolamine group, mannose,
galactose, sialic acid, or other sugars (blue, Figure 1) (2).
Table 1 lists a number of GPI-anchored proteins and the
structures of their various side chains and lipids (4, 6, 13,
16, 18–24). The phosphoethanolamine side chain, attached
to either the second or third mannose of the glycan core, is
only found in higher eukaryotes, not in protozoa. The most
common side chain attached to the ﬁrst mannose residue is
another mannose. Complex side chains, such as the N-
acetylgalactosamine-containing polysaccharides attached to
the third mannose of the glycan core, are found in both
mammalian and protozoan anchor structures. The core
Table 1: Representative Structures of Known GPI Anchors (4, 6, 13, 16, 18–24)
a
protein R1 R2 R3 R4 R5 R6 X
rat brain Thy-1 (ManR1-2 OH PEtN (GalNAc1-4 OH OH alkylacyl-glycerol
human erythrocyte AChE OH (PEtN PEtN OH OH palmitate alkylacyl-glycerol
hamster brain scrapie prion protein (ManR1-2 OH PEtN ((NANA)- ((Gal)-GalNAc1-4O H O H n d
human urine CD59 (ManR1-2 OH PEtN (GalNAc1-4 OH palmitate nd
mouse skeletal muscle NCAM (ManR1-2 nd PEtN (GalNAc1-4O H O H n d
bovine liver 5′-nucleotidase (ManR1-2 (PEtN PEtN (HexNAc OH OH nd
human placental APase OH (PEtN PEtN OH OH OH alkylacyl-glycerol
human CD52 (ManR1-2 (PEtN PEtN OH OH palmitate diacyl-glycerol
pig kidney membrane dipeptidase OH (PEtN PEtN ((Gal1-3)GalNAc1-4o r
((NANA) - GalNAc1-4
OH OH diacyl-glycerol
human kidney membrane dipeptidase (ManR1-2 nd PEtN ((Gal1-3)GalNAc1-4O H O H n d
T. brucei VSG OH OH OH (GalR1-2(GalR1-2GalR1-6)
GalR1-3
OH OH dimyristyl-glycerol
T. cruzi 1G7 (ManR1-2 OH OH OH OH OH alkylacyl-glycerol
T. cruzi NETNES (ManR1-2 OH OH OH PEtN OH alkylacyl-glycerol
L. major gp63 OH OH OH OH OH OH alkylacyl-glycerol
S. cereVisiae gp125 (ManR1-2ManR1-2o r
ManR1-3ManR1-2
OH OH OH OH OH diacyl-glycerol
A. fumigatus PhoAp (ManR1-3ManR1-2 OH OH OH OH OH ceramide
P. communis arabinogalactan proteins OH OH OH (GalNAc1-4 OH OH ceramide
D. Discoideum PsA (ManR1-2 nd nd OH OH OH ceramide
a Various side chain modiﬁcations of carbohydrates, phosphoethanolamine, and/or palmitate (R1-R6) are indicated. In some proteins, certain side
chains may only be present in a proportion of GPI anchors (indicated by (). OH indicates that no side chain is known to be present; nd indicates that
the side chain or lipid moiety has not been determined. X is the lipid moiety, Man is mannose, Gal is galactose, GalNAc is N-acetylgalactosamine,
NANA is sialic acid, HexNAc is N-acetylhexosamine, and PEtN is phosphoethanolamine.
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NETNES, a glycoprotein of unknown function from T. cruzi
(23). Depending on the protein and species of origin, the
lipid anchor of the phosphoinositol ring is a diacylglycerol,
an alkylacylglycerol, or a ceramide (24). The lipid species
vary in length, ranging from 14 to 28 carbons, and can be
either saturated or unsaturated. Many GPI anchors also
contain an additional fatty acid, such as palmitic acid, on
the 2-hydroxyl of the inositol ring. This extra fatty acid
renders the GPI anchor resistant to cleavage by PI-PLC (24).
FUNCTIONS OF GPI-ANCHORED PROTEINS
The GPI anchor is broadly distributed among eukaryotic
organisms, including protozoa, fungi, plants, insects, and
mammals (1). Among vertebrates, GPI-anchored proteins have
been identiﬁed throughout every major cell type and tissue. GPI-
anchored proteins vary widely in size, ranging from the 12
amino acid glycopeptide CD52 to the 175 kDa protein CDw109
(1). To date, more than 250 proteins have been found to contain
a GPI anchor (3, 8). Importantly, GPI anchors are essential for
viability. Defects in GPI anchor biosynthesis are embryonic
lethal in mammals and conditionally lethal in yeast (25, 26).
The connection between GPI anchor structural diversity
and function is poorly understood. GPI-anchored proteins
display diverse biological functions, some of which are listed
in Table 2. Many of these proteins have enzymatic activity,
such as APase, which catalyzes the removal of phosphate
groups from biomolecules (2). Certain GPI-anchored proteins
are involved in cell-cell contact and adhesion, such as an
isoform of the neural cell adhesion molecule (NCAM). The
GPI-anchored proteins CD55 (decay-accelerating factor or
DAF) and CD59 are important in the regulation of the
complement cascade, which protects an organism from
foreign invaders and pathogens (2). VSG, a GPI-anchored
protein from T. brucei, forms a protective coat around the
trypanosome parasite (3). Although many GPI-anchored
proteins have been characterized, some GPI-anchored pro-
teins, like the prion protein, do not yet have an assigned
function (27).
UNIQUE PROPERTIES OF GPI-ANCHORED
PROTEINS MEDIATED BY THE GPI ANCHOR
GPI-Anchored Proteins May Associate with Lipid Raft
Domains GPI-anchored proteins are believed to associate
with lipid rafts, membrane microdomains enriched in gly-
cosphingolipids, cholesterol, and certain types of lipidated
proteins (Figure 2) (28, 29). Lipid rafts organize the plasma
membrane into a series of discrete smaller domains that can
serve as platforms for a variety of cellular functions, such
as vesicular trafﬁcking and signal transduction (28, 29). Lipid
rafts are hypothesized to form by the self-association of
sphingolipids, favored by their long and mostly saturated
hydrocarbons that allow them to pack tightly in a bilayer.
Cholesterol molecules are believed to ﬁll the voids between
the associating sphingolipids (28). The presence of choles-
terol may be necessary for the function and formation of
lipid rafts, as depletion of cellular cholesterol has been shown
to disrupt these rafts (28). Due to the tight packing of
sphingolipids, lipid rafts are believed to be less ﬂuid than
the surrounding phospholipid bilayer (28). The highly ordered
environment of the lipid rafts may also allow for the close
packing of GPI-anchored proteins. These lipid rafts were ﬁrst
characterized by their insolubility at 4 °C in the nonionic
detergent Triton X-100, which has become the most widely
used assay for raft existence (28, 29). GPI-anchored proteins
also are detergent insoluble under these conditions, presum-
ably due to their association with lipid rafts (28). Common
signaling proteins are also found in these complexes, which
has led to the hypothesis that the GPI anchor may be
important in signal transduction (30).
Table 2: Representative Functions of GPI-Anchored
Proteins (2, 3, 17, 27)
biological role protein source
enzymes alkaline phosphatase mammalian tissues,
Schistosoma
5′-nucleotidase mammalian tissues
acetylcholinesterase Torpedo electric organ,
insect brain, mammalian
blood cells
dipeptidase pig and human kidney,
sheep lung
cell-cell interaction LFA-3 human blood cells
NCAM mammalian and chicken
brain and muscle
PH-20 guinea pig sperm
complement regulation CD55 (DAF) human blood cells
CD59 human blood cells
mammalian antigens Thy-1 mammalian brain and
lymphocytes
Qa-2 mouse lymphocytes
CD14 human monocytes
carcinoembryonic
antigen (CEA)
human tumor cells
CD52 human lymphocytes
protozoan antigens VSG T. brucei
1G7 T. cruzi
procyclin T. brucei
miscellaneous scrapie prion protein hamster brain
CD16b human neutrophils
folate-binding protein human epithelial cells FIGURE 2: Membrane-associated proteins in a lipid bilayer contain-
ing lipid raft domains. GPI-anchored proteins and other lipidated
proteins are believed to associate with lipid rafts.
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to their proposed small size and dynamic nature (29, 31, 32).
Common assays used to probe for the presence of rafts
include cholesterol depletion and detergent extraction, but
these assays are indirect and plagued by artifacts (29, 31).
Methods used to determine the size of lipid rafts have given
conﬂicting results, and both ﬂuorescence and electron
microscopy have consistently failed to prove the existence
of lipid rafts enriched in GPI-anchored proteins in living
cells (29, 32). Using imaging ﬂuorescence resonance energy
transfer (FRET) microscopy, Kenworthy and Edidin visual-
ized antibody-labeled 5′-nucleotidase in MDCK cells (33).
Their data were in agreement with a model that suggested
that most 5′-nucleotidase molecules were randomly distrib-
uted on the plasma membrane of these cells. Glebov and
Nichols found that the FRET signal from GPI-anchored
ﬂuorescent proteins in COS-7 and Jurkat cells was similar
to the signal measured for nonraft proteins (34). Cholesterol
depletion using -methyl cyclodextrin also did not affect the
FRET signal, suggesting that the GPI-anchored ﬂuorescent
proteins were not clustered in cholesterol-dependent lipid
rafts (34). However, these conclusions can be questioned if
the rafts are very small (5 nm or less) or if the GPI-anchored
proteins are not present at high enough concentrations in the
plasma membrane (32, 34).
Other studies, using specialized microscopy and additional
techniques, have given support for the existence of GPI-
anchored proteins in lipid rafts. Using depolarization FRET
microscopy, Varma and Mayor demonstrated that GPI-
anchored proteins were organized in cholesterol-dependent
microdomains with diameters less than 70 nm in living cells
(35). Friedrichson and Kurzchalia also investigated the
existence of GPI-anchored proteins in lipid rafts by chemi-
cally cross-linking GPI-anchored growth hormone (GH-GPI)
with short (1.1 nm) cross-linkers and analyzing the cross-
linking efﬁciency (36). The extent of cross-linking was found
to be independent of the amount of GH-GPI expressed by
the cells, suggesting that GPI-anchored proteins clustered
in lipid rafts. Recently, Sharma and co-workers employed a
technique known as homo-FRET to look at GPI-anchored
ﬂuorescent proteins and determined that a small fraction of
GPI-anchored proteins were organized into nanometer size
(∼4-5 nm) raft domains (32). The authors concluded that
20-40% of GPI-anchored proteins were present in rafts and
that each cluster consisted of four or fewer GPI-anchored
proteins (32). Although the existence of lipid rafts and the
enrichment of GPI-anchored proteins in these domains is a
highly controversial subject (29), a variety of new tools and
techniques have recently been developed that can be used
to further investigate the association of GPI-anchored proteins
with lipid rafts.
GPI-Anchored Proteins Can Be Exogenously Incorporated
onto Cell Surfaces. Since the lipid tail of the GPI anchor
does not completely extend through the lipid bilayer, GPI-
anchored proteins are associated more loosely with the
plasma membrane than transmembrane proteins. In fact,
many GPI-anchored proteins can transfer spontaneously to
cell membranes both in Vitro and in ViVo, a process that has
been termed “cell surface painting” (2, 37). Before the
structure of the GPI anchor was known, puriﬁed human DAF
was shown to insert onto sheep erythrocytes (37). Exog-
enously added DAF was freely mobile on the sheep cell
surface and was able to function normally as shown by its
inhibition of convertase complexes. Since then, numerous
GPI-anchored proteins have been incorporated onto a variety
of different cell types (2, 37). Generally, these exogenously
added GPI-anchored proteins retained the same character-
istics and functions as endogenously expressed GPI-anchored
proteins (2, 37). While the mechanism by which this transfer
process occurs is unknown, the lipid moieties of the GPI
anchor must be intact for cell membrane insertion (37).
Intermembrane transfer of GPI-anchored proteins also can
occur in ViVo. Kooyman et al. engineered transgenic mice
to express the human GPI-anchored proteins DAF and CD59
solely on the surface of their red blood cells (38). Immu-
nohistology studies on the tissues from these mice detected
both proteins on vascular endothelial cells from several
organs, in addition to erythrocytes. Erythrocyte studies on
human patients with African trypanosomiasis found that their
cells contained membrane-bound VSG trypanosomal coat
proteins (37). The results from these and other studies
indicate that GPI-anchored proteins can spontaneously
transfer from one cell to another in ViVo.
The ability of GPI-anchored proteins to be inserted into
cell membranes has been exploited to modulate host immune
responses. Huang and colleagues generated the puriﬁed GPI-
anchored MHC class I molecule HLA-A2.1 complexed to
an antigenic peptide from hepatitis B virus (39). This GPI-
anchored protein was transferred to MHC-class-I-negative
cells, which were then able to activate speciﬁc T-cells. In
another study, McHugh and co-workers immunized mice
with EG7 tumors expressing GPI-anchored B7-1 via cell
surface painting, which induced tumor-speciﬁc T-cell pro-
liferation and cytolytic T lymphocytes (40). These mice were
protected when challenged with live wild-type tumor cells.
These studies demonstrate that exogenously added GPI-
anchored proteins are functional in ViVo and can potentially
be used as therapeutic agents.
SIGNIFICANCE AND FUNCTIONS OF THE GPI
ANCHOR
Despite continued attempts to characterize the functions
of GPI-anchored proteins, the signiﬁcance of the GPI anchor
structure has yet to be deduced (1, 10, 11). The GPI anchor
could have a genuine functional role in some or all anchored
proteins, or it could merely be a vestigial relic. The only
conﬁrmed role of the GPI anchor is to provide the attached
protein with a stable membrane anchoring device that is
resistant to most extracellular proteases and lipases (10, 11).
Given that there are many ways in which a protein can be
attached to the cell membrane, the GPI anchor is a fairly
complicated structure when compared to a simple lipid or
transmembrane domain. It is possible that the GPI anchor
serves other biological functions besides a membrane anchor.
The GPI Anchor May Affect the Structure of Its Associated
Protein. The GPI anchor may inﬂuence the conformation
and structure of the protein to which it is attached. For
example, an antibody that binds the GPI-anchored protein
procyclin from T. brucei shows greatly reduced afﬁnity
toward the same protein lacking the lipid tail (41). The OX7
antibody that recognizes the GPI-anchored Thy-1 protein also
fails to bind Thy-1 after treatment with PI-PLC (42). In
addition, the circular dichroism spectra of GPI-anchored
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Taken together, these results suggest that the GPI anchor
may affect the overall conformation of its attached protein.
The GPI anchor may also inﬂuence protein structure by
interacting directly with or causing the protein to interact
with the cell membrane. Based on a combination of two-
dimensional NMR analysis and molecular modeling, Homans
and co-workers proposed that the glycan core of the VSG
GPI anchor exists in an extended conformation that lies along
the plane of the plasma membrane (43). Computer modeling
has also been used to suggest that the glycan portion of the
Thy-1 GPI anchor occupies a carbohydrate-binding site of
the protein domain (44). In this model, the protein portion
of Thy-1 sits directly on the cell membrane with most of its
GPI anchor buried within the protein. FRET studies of
ﬂuorescently labeled, GPI-anchored human placental alkaline
phosphatase (PLAP) in artiﬁcial lipid bilayers found that the
protein portion sits less than 10-14 Å away from the bilayer
(45). Contact between the PLAP protein moiety and the lipid
bilayer might allow for transmission of structural changes
or signals between the cell membrane and the GPI-anchored
protein (45).
The GPI Anchor May Be InVolVed in Signal Transduction.
The GPI anchor may also act as an intermediary between
the exterior of a cell and internal signaling molecules (46, 47).
As mentioned earlier, the GPI anchor may allow for signal
transduction by GPI-anchored proteins (2, 30). Antibody
cross-linking of some GPI-anchored proteins can effect the
transduction of cellular activation or inhibition signals,
resulting in Ca2+ ﬂuxes, protein tyrosine phosphorylation,
or cytokine secretion (2, 46, 47). These effects are not
generally observed with genetically engineered forms of GPI
proteins, where the GPI anchor has been replaced with a
transmembrane domain, indicating that the GPI anchor is
crucial for these signaling events (2, 46, 47). Although the
GPI anchor does not completely cross the cell membrane, it
has been postulated that the transduction of cellular signals
occurs through the physical association of the GPI anchor
with other transmembrane proteins involved in intracellular
signaling (2). In support of this hypothesis, certain GPI-
anchored proteins have been found to associate with trans-
membrane signal transduction partners, such as protein
tyrosine kinases, integrins, and heterotrimeric GTP-binding
proteins (2, 30, 46, 47).
The GPI Anchor May Facilitate Cellular Communication.
Many GPI-anchored proteins involved in signaling and
cell-cell communication, such as DAF and Thy-1, diffuse
freely on the cell surface, allowing these proteins to move
rapidly in response to external stimuli (11). This high
mobility has been postulated to facilitate cell-cell interac-
tions and communication (11). For instance, the high lateral
mobility of DAF may allow it to interact with and inhibit
membrane-associated complement fragments. Other GPI-
anchored proteins, such as NCAM, are involved in cellular
adhesion and communication and might beneﬁt from the
ability to move rapidly on the cell surface in response to
external stimuli.
The GPI Anchor May Act as an Apical Targeting Signal.
Another possible function of the GPI anchor is to act as a
targeting device. In polarized cells, different domains of the
plasma membrane display different protein and lipid com-
positions, allowing for a variety of specialized functions in
each domain (48). Known as the apical and basolateral
domains, these domains are separated by tight junctions and
are important to the cell for maintaining asymmetric growth,
directional migration, or transport and delivery of signals
and nutrients. Since many GPI-anchored proteins are deliv-
ered to the apical membrane, the GPI anchor has been
proposed to act as an apical targeting signal (reviewed in
ref 48). In 1992, Brown and Rose used detergent extraction
to determine that human PLAP expressed in MDCK cells, a
polarized epithelial cell line, was associated with lipid rafts
during transport through the Golgi and subsequently to the
apical surface (49). Based on this and other data, it was
postulated that lipid rafts may act as platforms for the
formation of apical targeting vesicles (48, 49). Due to their
presumed inclusion in lipid rafts, the GPI anchor was
believed to be an apical targeting domain by mediating
association of a protein with these lipid raft domains (48, 49).
However, epithelial Fisher rat thyroid cells trafﬁcked most
of their GPI-anchored proteins to the basolateral surface,
while some apical proteins in polarized MDCK cells did not
even associate with lipid rafts (48, 50). Further investigations
have implicated N-glycosylation and oligomerization in the
apical sorting of GPI-anchored proteins (51, 52). Taken
together, these studies suggest that a number of mechanisms
may be responsible for the sorting of many GPI-anchored
proteins to the apical surface in polarized epithelial cells.
The GPI Anchor May Allow for Regulation of Its Associ-
ated Protein Via Phospholipase CleaVage. The susceptibility
of the GPI anchor to cleavage from its associated protein by
phospholipases, such as PI-PLC and phopholipase D, has
been suggested as a mechanism for the selective regulation
of GPI-anchored proteins (10, 11). Phospholipase-mediated
release is rapid and may be used by the cell to secrete certain
GPI-anchored proteins at a speciﬁc time. GPI anchors with
an extra fatty acid attached to the inositol moiety are
phospholipase-resistant, which may allow for cell- or protein-
speciﬁc control over the release of GPI-anchored proteins.
The cleavage of the GPI anchor from a protein may also be
used to disrupt the adhesion between cells. Alternatively,
the products released from phospholipase cleavage of a GPI-
anchored protein, such as inositol phospholipids, may be
involved in signal transduction pathways or cellular com-
munication (10).
The GPI Anchor Binds to Bacterial Toxins. Aerolysin is
a bacterial toxin secreted by Aeromonas hydrophilia impli-
cated in the virulence of this human pathogen (53). This toxin
is a hydrophilic protein that binds to certain sensitive cells
and forms oligomers that insert into the cell membrane (53).
The aerolysin oligomers form channels in the plasma
membrane that kill the cell (53). Known aerolysin receptors,
such as Thy-1 and contactin, seem to be unrelated in function;
however, they all contain GPI anchors (53). In 1998, Diep
and colleagues demonstrated that the GPI anchor of these
target proteins was an important binding determinant for
aerolysin (53). In addition, Fukushima et al. determined that
-N-acetylglucosamine, a side chain on the GPI anchor of
human PLAP, was necessary for aerolysin binding (54).
However, certain GPI-anchored proteins bound strongly to
aerolysin, while others did not, suggesting that the variable
regions of the GPI anchor, such as the sugar or phosphoet-
hanolamine side chains, were responsible for this speciﬁcity
(53). Recently, another pore-forming toxin, alpha toxin from
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anchor (55). Since GPI-anchored proteins appear to be
clustered on the cell surface, it has been speculated that
binding of these bacterial toxins to the GPI anchor facilitates
their concentration and oligomerization, thus allowing for
toxin insertion into host cell membranes (53).
The GPI Anchor May Be InVolVed in Prion Disease
Pathogenesis. Prion disease is characterized by the formation
of insoluble protein plaques within neurons and related cells
in the brain, which are associated with neurodegeneration
(27). Plaque formation involves a conformational change of
the normal cellular prion protein PrPC, a GPI-anchored
protein, to the pathogenic scrapie form, PrPSc (27). Although
the normal function of PrPC is still unknown, it has been
suggested to be a signaling molecule (27). Plaque formation
might interfere with the normal prion signaling function,
leading to neuronal death.
PrPC, like many GPI-anchored proteins, is able to migrate
from one cell membrane to another (56). This transfer
requires cellular activation by phorbol 12-myristate 13-
acetate, direct cell-cell contact, and an intact GPI anchor
(56). It is not known whether PrPSc also undergoes intercel-
lular transfer. If so, the process may permit PrPSc to infect
healthy, PrPC-containing cells. Alternatively, intercellular
transfer of PrPC may allow PrPSc-infected cells to recruit PrPC
from healthy cells, thus providing the infected cells with more
PrPC substrate for propagation of PrPSc.
Recently, the GPI anchor of PrPC was discovered to play
a potential role in prion disease pathogenesis (9, 57). When
infected with PrPSc, transgenic mice that expressed an
anchorless, secreted version of PrPC never developed clinical
prion disease (9). However, the brains of these mice still
contained PrPSc plaques that are normally associated with
clinical disease progression. Thus, removal of the GPI anchor
from PrPC did not prevent the generation of PrPSc plaques
but somehow undermined the genesis of prion disease. It is
possible that the lack of a GPI anchor on PrPC prevents the
delivery of neurotoxic signals after PrPSc plaque formation
(Figure 3).
STRUCTURAL SIGNIFICANCE OF THE GPI
ANCHOR
The relationship between the structures and functions of
the GPI anchor is difﬁcult to study due to the lack of
sufﬁcient quantities of pure anchors and anchored proteins.
When produced in cells, GPI-anchored proteins exist as
heterogeneous mixtures with considerable variation in their
glycan core modiﬁcations and lipid moieties, a complicating
feature with respect to functional analysis (1, 13, 18, 58).
Furthermore, well-deﬁned modiﬁcations to the GPI anchor
structure cannot be imposed using conventional biological
methods; the biosynthetic enzymes are not well characterized,
and their disruption in cells simply leads to loss of the entire
GPI structure (7, 8, 14, 25, 59).
Chemical synthesis can provide access to both native and
novel GPI-anchored protein structures, providing valuable
material for functional studies. Several total syntheses of
native GPI anchors have been reported; however, these routes
are complicated and not amenable to structural modiﬁcation
(reviewed in ref 60). More importantly, most synthetic routes
do not provide an avenue for coupling the anchor structure
to a protein, the state in which they function naturally (60).
Recently, Shao et al. attached a synthetic 12-amino acid
glycopeptide from CD52, a GPI-anchored peptide, to a
synthetically produced GPI anchor (61). However, almost
all known GPI-anchored proteins are considerably larger than
12 amino acids and are not readily accessible by routine
peptide synthesis.
An additional motivation for the synthesis of GPI anchors
derives from their potential clinical utility. Certain eukaryotic
parasites, such as T. brucei, Leishmania, and Plasmodium
falciparum have an abundance of GPI-anchored proteins on
the plasma membrane. Their GPI anchor structures differ
from those found in mammals with respect to decorations
of the core pentasaccharide and/or lack of an associated
protein. Because of these differences, the parasite’s GPI
anchor is often an immunodominant epitope and, accordingly,
synthetic variants have been explored as vaccine candidates
and for the characterization of malaria-induced antibody
responses (62, 63).
To circumvent the difﬁculty in native GPI anchor syn-
FIGURE 3: A proposed model for the role of the GPI anchor in the conversion of PrPC to PrPSc and progression to clinical disease (9). (A)
When exposed to PrPSc, GPI-anchored PrPC is converted into aggregates of PrPSc. The aggregates may interfere with the normal signaling
events involving PrPC, leading to neuron death. (B) Transgenic mice expressing PrPC lacking a GPI anchor still form PrPSc aggregates upon
infection with exogenous PrPSc. However, these aggregates may be unable to disrupt signal transduction pathways due to the lack of a GPI
anchor. Figure adapted from ref 57. Copyright 2005 AAAS.
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or proteins attached to GPI anchor substitutes (Figure
4) (64–70). These GPI anchor replacements were designed
to act solely as membrane-anchoring devices rather than
emulating the complex structure of a native GPI anchor.
Since none of these GPI anchor substitutes contained sugars,
the contributions of the various monosaccharides within the
glycan core to the biological functions of the GPI anchor
could not be assessed. Nevertheless, these substitutes did
allow for some interesting structural and functional studies
of lipid-modiﬁed prion proteins (PrPs). For example, both
the circular dichroism spectra of 2, when incorporated into
liposomes, and the infrared spectrum of liposome-incorpo-
rated 4 were similar to the respective spectra of soluble
PrP (65, 68). These results suggest that structures determined
from the soluble protein may represent the conformations
adopted by the cell surface-bound, GPI-anchored PrPC (65, 68).
In another study, lipidated PrP 7 was able to incorporate into
cellular membranes and was found to ﬂoat at a different
concentration of sucrose than natively anchored PrPC in a
sucrose gradient ﬂoatation assay (70). This discrepancy is
most likely the result of structural differences between the
native PrPC GPI anchor and the GPI anchor substitution
found on 7.
In an effort to deﬁne the functional signiﬁcance of the
GPI glycan core, our laboratory has recently synthesized a
series of GPI anchor analogues bearing systematic modiﬁca-
tions to the core structure (Figure 5) (71). The analogues
were similar in length to the native GPI anchor, contained
no (8), one (9), or two (10) mannose units, and replaced the
phosphoinositol and glucosamine units with a simple hy-
drophilic poly(ethylene glycol) (PEG) linker. These ana-
logues were coupled to the green ﬂuorescent protein (GFP)
using native chemical ligation (71). The GPI-protein ana-
logues all incorporated into cellular membranes and trafﬁcked
to recycling endosomes similarly to GFP bearing a native
GPI anchor (GFP-GPI) (72). This result suggests that the
glycan core of the GPI anchor is not a major determinant of
the intracellular fate of GPI-anchored proteins. However,
deletions in the GPI anchor glycan core signiﬁcantly altered
the diffusion kinetics of these proteins in the cell membrane.
Fluorescence correlation spectroscopy revealed that all three
GPI-protein analogues diffused more slowly on the cell
membrane than natively anchored GFP-GPI, suggesting that
the sugars of the glycan core affect the lateral mobility of
GPI-anchored proteins (72). The GPI anchor analogues we
designed contained ﬂexible PEG linkers, which may permit
greater movement of the attached protein, thus allowing the
FIGURE 4: Structures of peptides/proteins attached to GPI anchor substitutes (64–70). The GPI anchor replacement structures were chemically
synthesized and coupled to either expressed proteins or chemically synthesized peptides or proteins. Single letter abbreviations are used for
amino acids (2 and 7). PrP106 is the 106-amino acid truncated mouse prion protein (64), PrP(23-231) is the truncated mouse (2)o r
hamster (4) prion protein (65, 68), PrP(214-231) is a fragment of the human prion protein (66), PrP(S230C) is the truncated mouse prion
protein with a serine-to-cysteine mutation at residue 230 (69), GFP is enhanced green ﬂuorescent protein (67), and PrP(90-232) is the
truncated mouse prion protein (70).
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other cell surface proteins. Such transient interactions would
be expected to retard diffusion. The additional sugar moieties
in the native GPI structure might sufﬁciently rigidify the
anchor so as to avoid nonspeciﬁc membrane interactions.
These studies demonstrate that the GPI anchor may be more
than a membrane anchor and that the sugars of the GPI
anchor may play an important role in regulating the behavior
of the attached protein. Furthermore, this cellular system
provides a basic platform for dissecting the contributions of
various GPI anchor components to their biological function.
CONCLUSIONS AND PERSPECTIVES
The GPI anchor is a structurally complex posttranslational
modiﬁcation that remains a mystery with respect to its
biological activities. A major obstacle to functional inves-
tigations is the difﬁculty in producing structurally deﬁned
GPI moieties and GPI-anchored proteins. Cells generate
heterogeneous mixtures of both anchor and modiﬁed protein
structures, and chemical synthesis requires numerous difﬁcult
synthetic transformations. Nonetheless, there have been many
advances in the production of these structures, including a
recent report detailing a method for the expression of GPI-
anchored proteins in insect cells (73). The GPI anchor
biosynthetic pathway has been elucidated, and many of the
enzymes have been characterized. Application to the large-
scale production of GPI anchors and modiﬁed proteins may
be on the horizon. Furthermore, recent progress in the
chemical synthesis of GPI anchors and GPI-anchored proteins
allows for the generation of native and modiﬁed structures
that can be used for the systematic investigation of the
biological function. In particular, the approach pursued by
our laboratory can be further expanded upon with GPI
analogues bearing more subtly modiﬁed monosaccharide
units, various side chain modiﬁcations, or lipid modiﬁcations.
Comparison of the proteins bearing modiﬁed and natural
anchor structures might reveal differences in membrane
protein organization or association with other proteins.
Additionally, GPI anchor analogues might be coupled to PrPC
for studies of its conversion to PrPSc in cell-based functional
assays.
Detailed structural information would be extremely useful
in forming hypotheses regarding the functions of the GPI
anchor. Unfortunately, the ﬂexibility of glycosidic linkages
and the solubility issues inherent to lipids have rendered GPI-
modiﬁed proteins difﬁcult to crystallize or to study by NMR.
To date, none of the GPI-anchored protein structures that
have been determined by X-ray crystallography contained
their GPI anchor. No NMR solution structures of GPI-
anchored proteins are available either. Emerging techniques
that limit the ﬂexibility of the GPI anchor or assemble GPI-
anchored proteins into ordered arrays (e.g., bicelles (74))
should facilitate structural studies in the future.
REFERENCES
1. Nosjean, O., Briolay, A., and Roux, B. (1997) Mammalian GPI
proteins: sorting, membrane residence and functions. Biochim.
Biophys. Acta 1331, 153–186.
2. Low, M. (1999) GPI-anchored biomoleculessan oVerView, in GPI-
anchored membrane proteins and carbohydrates (Hoessli, D. C.,
and Ilangumaran, S., Eds.) pp 1-14, Landes Company, Austin,
TX.
3. Ferguson, M. A. (1999) The structure, biosynthesis and functions
of glycosylphosphatidylinositol anchors, and the contributions of
trypanosome research. J. Cell Sci. 112, 2799–2809.
4. Ferguson, M. A., Homans, S. W., Dwek, R. A., and Rademacher,
T. W. (1988) Glycosyl-phosphatidylinositol moiety that anchors
Trypanosoma brucei variant surface glycoprotein to the membrane.
Science 239, 753–759.
5. Ferguson, M. A., Low, M. G., and Cross, G. A. (1985) Glycosyl-
sn-1,2-dimyristylphosphatidylinositol is covalently linked to Try-
panosoma brucei variant surface glycoprotein. J. Biol. Chem. 260,
14547–14555.
6. Homans, S. W., Ferguson, M. A., Dwek, R. A., Rademacher, T. W.,
Anand, R., and Williams, A. F. (1988) Complete structure of the
glycosyl phosphatidylinositol membrane anchor of rat brain Thy-1
glycoprotein. Nature 333, 269–272.
7. Eisenhaber, B., Maurer-Stroh, S., Novatchkova, M., Schneider, G.,
and Eisenhaber, F. (2003) Enzymes and auxiliary factors for GPI
lipid anchor biosynthesis and post-translational transfer to proteins.
BioEssays 25, 367–385.
8. Tiede, A., Bastisch, I., Schubert, J., Orlean, P., and Schmidt, R. E.
(1999) Biosynthesis of glycosylphosphatidylinositols in mammals
and unicellular microbes. Biol. Chem. 380, 503–523.
9. Chesebro, B., Triﬁlo, M., Race, R., Meade-White, K., Teng, C.,
LaCasse, R., Raymond, L., Favara, C., Baron, G., Priola, S.,
Caughey, B., Masliah, E., and Oldstone, M. (2005) Anchorless
prion protein results in infectious amyloid disease without clinical
scrapie. Science 308, 1435–1439.
FIGURE 5: Structures of GPI-protein analogues bearing systematic deletions in the glycan core (71). The GPI anchor analogues possess no
monosaccharides (8), one mannosyl unit (9), or two mannosyl units (10) and were coupled to GFP using native chemical ligation. These
GPI-protein analogues were used to investigate the functional signiﬁcance of the GPI anchor glycan core (72).
6998 Biochemistry, Vol. 47, No. 27, 2008 Current Topics10. Low, M. G. (1989) Glycosyl-phosphatidylinositol: a versatile
anchor for cell surface proteins. FASEB J. 3, 1600–1608.
11. Low, M. G., and Saltiel, A. R. (1988) Structural and functional
roles of glycosyl-phosphatidylinositol in membranes. Science 239,
268–275.
12. Ferguson, M. A., Brimacombe, J. S., Brown, J. R., Crossman, A.,
Dix, A., Field, R. A., Guther, M. L., Milne, K. G., Sharma, D. K.,
and Smith, T. K. (1999) The GPI biosynthetic pathway as a
therapeutic target for African sleeping sickness. Biochim. Biophys.
Acta 1455, 327–340.
13. Ikezawa, H. (2002) Glycosylphosphatidylinositol (GPI)-anchored
proteins. Biol. Pharm. Bull. 25, 409–417.
14. Kinoshita, T., and Inoue, N. (2000) Dissecting and manipulating
the pathway for glycosylphos-phatidylinositol-anchor biosynthesis.
Curr. Opin. Chem. Biol. 4, 632–638.
15. Orlean, P., and Menon, A. K. (2007) Thematic review series: lipid
posttranslational modiﬁcations. GPI anchoring of protein in yeast
and mammalian cells, or: how we learned to stop worrying and
love glycophospholipids. J. Lipid Res. 48, 993–1011.
16. Deeg, M. A., Humphrey, D. R., Yang, S. H., Ferguson, T. R.,
Reinhold, V. N., and Rosenberry, T. L. (1992) Glycan components
in the glycoinositol phospholipid anchor of human erythrocyte
acetylcholinesterase. Novel fragments produced by triﬂuoroacetic
acid. J. Biol. Chem. 267, 18573–18580.
17. Low, M. G. (1989) The glycosyl-phosphatidylinositol anchor of
membrane proteins. Biochim. Biophys. Acta 988, 427–454.
18. Brewis, I. A., Ferguson, M. A. J., Mehlert, A., Turner, A. J., and
Hooper, N. M. (1995) Structures of the glycosyl-phosphatidyli-
nositol anchors of porcine and human renal membrane dipeptidase.
Comprehensive structural studies on the porcine anchor and
interspecies comparison of the glycan core structures. J. Biol. Chem.
270, 22946–22956.
19. Nakano, Y., Noda, K., Endo, T., Kobata, A., and Tomita, M. (1994)
Structural study on the glycosyl-phosphatidylinositol anchor and
the asparagine-linked sugar chain of a soluble form of CD59 in
human urine. Arch. Biochem. Biophys. 311, 117–126.
20. Mukasa, R., Umeda, M., Endo, T., Kobata, A., and Inoue, K. (1995)
Characterization of glycosylphosphatidylinositol (GPI)-anchored
NCAM on mouse skeletal muscle cell line C2C12: the structure
of the GPI glycan and release during myogenesis. Arch. Biochem.
Biophys. 318, 182–190.
21. Fontaine, T., Magnin, T., Melhert, A., Lamont, D., Latge, J. P.,
and Ferguson, M. A. (2003) Structures of the glycosylphosphati-
dylinositol membrane anchors from Aspergillus fumigatus mem-
brane proteins. Glycobiology 13, 169–177.
22. Oxley, D., and Bacic, A. (1999) Structure of the glycosylphos-
phatidylinositol anchor of an arabinogalactan protein from Pyrus
communis suspension-cultured cells. Proc. Natl. Acad. Sci. U.S.A.
96, 14246–14251.
23. Macrae, J. I., Acosta-Serrano, A., Morrice, N. A., Mehlert, A., and
Ferguson, M. A. (2005) Structural characterization of NETNES, a
novel glycoconjugate in Trypanosoma cruzi epimastigotes. J. Biol.
Chem. 280, 12201–12211.
24. McConville, M. J., and Ferguson, M. A. (1993) The structure,
biosynthesis and function of glycosylated phosphatidylinositols in
the parasitic protozoa and higher eukaryotes. Biochem. J. 294, 305–
324.
25. Kawagoe, K., Kitamura, D., Okabe, M., Taniuchi, I., Ikawa, M.,
Watanabe, T., Kinoshita, T., and Takeda, J. (1996) Glycosylphos-
phatidylinositol-anchor-deﬁcient mice: implications for clonal
dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
Blood 87, 3600–3606.
26. Leidich, S. D., Drapp, D. A., and Orlean, P. (1994) A conditionally
lethal yeast mutant blocked at the ﬁrst step in glycosyl phosphati-
dylinositol anchor synthesis. J. Biol. Chem. 269, 10193–10196.
27. Taylor, D. R., and Hooper, N. M. (2006) The prion protein and
lipid rafts. Mol. Membr. Biol. 23, 89–99.
28. Rajendran, L., and Simons, K. (2005) Lipid rafts and membrane
dynamics. J. Cell Sci. 118, 1099–1102.
29. Munro, S. (2003) Lipid rafts: elusive or illusive? Cell 115, 377–
388.
30. Simons, K., and Toomre, D. (2000) Lipid rafts and signal
transduction. Nat. ReV. Mol. Cell. Biol. 1, 31–39.
31. Pierce, S. K. (2004) To cluster or not to cluster: FRETting over
rafts. Nat. Cell Biol. 6, 180–181.
32. Sharma, P., Varma, R.,., Sarasij, R. C., Ira, Gousset, K., Krish-
namoorthy, G., Rao, M., and Mayor, S. (2004) Nanoscale organiza-
tion of multiple GPI-anchored proteins in living cell membranes.
Cell 116, 577–589.
33. Kenworthy, A. K., and Edidin, M. (1998) Distribution of a
glycosylphosphatidylinositol-anchored protein at the apical surface
of MDCK cells examined at a resolution of <100 A using imaging
ﬂuorescence resonance energy transfer. J. Cell Biol. 142, 69–84.
34. Glebov, O. O., and Nichols, B. J. (2004) Lipid raft proteins have
a random distribution during localized activation of the T-cell
receptor. Nat. Cell Biol. 6, 238–243.
35. Varma, R., and Mayor, S. (1998) GPI-anchored proteins are
organized in submicron domains at the cell surface. Nature 394,
798–801.
36. Friedrichson, T., and Kurzchalia, T. V. (1998) Microdomains of
GPI-anchored proteins in living cells revealed by crosslinking.
Nature 394, 802–805.
37. Medof, M. E., Nagarajan, S., and Tykocinski, M. L. (1996) Cell-
surface engineering with GPI-anchored proteins. FASEB J. 10, 574–
586.
38. Kooyman, D. L., Byrne, G. W., McClellan, S., Nielsen, D., Tone,
M., Waldmann, H., Coffman, T. M., McCurry, K. R., Platt, J. L.,
and Logan, J. S. (1995) In vivo transfer of GPI-linked complement
restriction factors from erythrocytes to the endothelium. Science
269, 89–92.
39. Huang, J. H., Getty, R. R., Chisari, F. V., Fowler, P., Greenspan,
N. S., and Tykocinski, M. L. (1994) Protein transfer of preformed
MHC-peptide complexes sensitizes target cells to T cell cytolysis.
Immunity 1, 607–613.
40. McHugh, R. S., Nagarajan, S., Wang, Y. C., Sell, K. W., and
Selvaraj, P. (1999) Protein transfer of glycosyl-phosphatidylinositol-
B7-1 into tumor cell membranes: a novel approach to tumor
immunotherapy. Cancer Res. 59, 2433–2437.
41. Butikofer, P., Malherbe, T., Boschung, M., and Roditi, I. (2001)
GPI-anchored proteins: now you see ’em, now you don’t. FASEB
J. 15, 545–548.
42. Barboni, E., Rivero, B. P., George, A. J., Martin, S. R., Renoup,
D. V., Hounsell, E. F., Barber, P. C., and Morris, R. J. (1995) The
glycophosphatidylinositol anchor affects the conformation of Thy-1
protein. J. Cell Sci. 108, 487–497.
43. Homans, S. W., Edge, C. J., Ferguson, M. A., Dwek, R. A., and
Rademacher, T. W. (1989) Solution structure of the glycosylphos-
phatidylinositol membrane anchor glycan of Trypanosoma brucei
variant surface glycoprotein. Biochemistry 28, 2881–2887.
44. Rademacher, T. W., Edge, C. J., and Dwek, R. A. (1991) Dropping
anchor with the lipophosphoglycans. Curr. Biol. 1, 41–42.
45. Lehto, M. T., and Sharom, F. J. (2002) Proximity of the protein
moiety of a GPI-anchored protein to the membrane surface: a FRET
study. Biochemistry 41, 8368–8376.
46. Jones, D. R., and Varela-Nieto, I. (1998) The role of glycosyl-
phosphatidylinositol in signal transduction. Int. J. Biochem. Cell
Biol. 30, 313–326.
47. Robinson, P. J. (1997) Signal transduction via GPI-anchored
membrane proteins. AdV. Exp. Med. Biol. 419, 365–370.
48. Schuck, S., and Simons, K. (2006) Controversy fuels trafﬁcking
of GPI-anchored proteins. J. Cell Biol. 172, 963–965.
49. Brown, D. A., and Rose, J. K. (1992) Sorting of GPI-anchored
proteins to glycolipid-enriched membrane subdomains during
transport to the apical cell surface. Cell 68, 533–544.
50. Zurzolo, C., Lisanti, M. P., Caras, I. W., Nitsch, L., and Rodriguez-
Boulan, E. (1993) Glycosylphosphatidylinositol-anchored proteins
are preferentially targeted to the basolateral surface in Fischer rat
thyroid epithelial cells. J. Cell Biol. 121, 1031–1039.
51. Benting, J. H., Rietveld, A. G., and Simons, K. (1999) N-Glycans
mediate the apical sorting of a GPI-anchored, raft-associated protein
in Madin-Darby canine kidney cells. J. Cell Biol. 146, 313–320.
52. Paladino, S., Sarnataro, D., Pillich, R., Tivodar, S., Nitsch, L., and
Zurzolo, C. (2004) Protein oligomerization modulates raft partition-
ing and apical sorting of GPI-anchored proteins. J. Cell Biol. 167,
699–709.
53. Diep, D. B., Nelson, K. L., Raja, S. M., Pleshak, E. N., and
Buckley, J. T. (1998) Glycosylphosphatidylinositol anchors of
membrane glycoproteins are binding determinants for the channel-
forming toxin aerolysin. J. Biol. Chem. 273, 2355–2360.
54. Fukushima, K., Ikehara, Y., Kanai, M., Kochibe, N., Kuroki, M.,
and Yamashita, K. (2003) A beta-N-acetylglucosaminyl phosphate
diester residue is attached to the glycosylphosphatidylinositol
anchor of human placental alkaline phosphatase: a target of the
channel-forming toxin aerolysin. J. Biol. Chem. 278, 36296–36303.
55. Gordon, V. M., Nelson, K. L., Buckley, J. T., Stevens, V. L.,
Tweten, R. K., Elwood, P. C., and Leppla, S. H. (1999) Clostridium
septicum alpha toxin uses glycosylphosphatidylinositol-anchored
protein receptors. J. Biol. Chem. 274, 27274–27280.
Current Topics Biochemistry, Vol. 47, No. 27, 2008 699956. Liu, T., Li, R., Pan, T., Liu, D., Petersen, R. B., Wong, B. S.,
Gambetti, P., and Sy, M. S. (2002) Intercellular transfer of the
cellular prion protein. J. Biol. Chem. 277, 47671–47678.
57. Aguzzi, A. (2005) Cell biology. Prion toxicity: all sail and no
anchor. Science 308, 1420–1421.
58. Thomas, J. R., Dwek, R. A., and Rademacher, T. W. (1990)
Structure, biosynthesis, and function of glycosylphosphatidylinosi-
tols. Biochemistry 29, 5413–5422.
59. Bastisch, I., Tiede, A., Deckert, M., Ziolek, A., Schmidt, R. E.,
and Schubert, J. (2000) Glycosylphosphatidylinositol (GPI)-
deﬁcient Jurkat T cells as a model to study functions of GPI-
anchored proteins. Clin. Exp. Immunol. 122, 49–54.
60. Guo, Z., and Bishop, L. (2004) Chemical synthesis of GPIs and
GPI-anchored glycopeptides. Eur. J. Org. Chem. 2004, 3585–3596.
61. Shao, N., Xue, J., and Guo, Z. (2004) Chemical synthesis of a
skeleton structure of sperm CD52-A GPI-anchored glycopeptide.
Angew. Chem., Int. Ed. 43, 1569–1573.
62. Kamena, F., Tamborrini, M., Liu, X., Kwon, Y. U., Thompson,
F., Pluschke, G., and Seeberger, P. H. (2008) Synthetic GPI array
to study antitoxic malaria response. Nat. Chem. Biol. 4, 238–240.
63. Schoﬁeld, L., Hewitt, M. C., Evans, K., Siomos, M. A., and
Seeberger, P. H. (2002) Synthetic GPI as a candidate anti-toxic
vaccine in a model of malaria. Nature 418, 785–789.
64. Ball, H. L., King, D. S., Cohen, F. E., Prusiner, S. B., and Baldwin,
M. A. (2001) Engineering the prion protein using chemical
synthesis. J. Pept. Res. 58, 357–374.
65. Eberl, H., Tittmann, P., and Glockshuber, R. (2004) Characteriza-
tion of recombinant, membrane-attached full-length prion protein.
J. Biol. Chem. 279, 25058–25065.
66. Musiol, H. J., Dong, S., Kaiser, M., Bausinger, R., Zumbusch, A.,
Bertsch, U., and Moroder, L. (2005) Toward semisynthetic
lipoproteins by convergent strategies based on click and ligation
chemistry. ChemBioChem 6, 625–628.
67. Grogan, M. J., Kaizuka, Y., Conrad, R. M., Groves, J. T., and
Bertozzi, C. R. (2005) Synthesis of lipidated green ﬂuorescent
protein and its incorporation in supported lipid bilayers. J. Am.
Chem. Soc. 127, 14383–14387.
68. Hicks, M. R., Gill, A. C., Bath, I. K., Rullay, A. K., Sylvester,
I. D., Crout, D. H., and Pinheiro, T. J. (2006) Synthesis and
structural characterization of a mimetic membrane-anchored prion
protein. FEBS J. 273, 1285–1299.
69. Breydo, L., Sun, Y., Makarava, N., Lee, C. I., Novitskaia, V.,
Bocharova, O., Kao, J. P., and Baskakov, I. V. (2007) Nonpolar
substitution at the C-terminus of the prion protein, a mimic of the
glycosylphosphatidylinositol anchor, partially impairs amyloid ﬁbril
formation. Biochemistry 46, 852–861.
70. Olschewski, D., Seidel, R., Miesbauer, M., Rambold, A. S.,
Oesterhelt, D., Winklhofer, K. F., Tatzelt, J., Engelhard, M., and
Becker, C. F. (2007) Semisynthetic murine prion protein equipped
with a GPI anchor mimic incorporates into cellular membranes.
Chem. Biol. 14, 994–1006.
71. Paulick, M. G., Wise, A. R., Forstner, M. B., Groves, J. T., and
Bertozzi, C. R. (2007) Synthetic analogues of glycosylphosphati-
dylinositol-anchored proteins and their behavior in supported lipid
bilayers. J. Am. Chem. Soc. 129, 11543–11550.
72. Paulick, M. G., Forstner, M. B., Groves, J. T., and Bertozzi, C. R.
(2007) A chemical approach to unraveling the biological function
of the glycosylphosphatidylinositol anchor. Proc. Natl. Acad. Sci.
U.S.A. 104, 20332–20337.
73. Shams-Eldin, H., Azzouz, N., Niehus, S., Smith, T. K., and
Schwarz, R. T. (2008) An efﬁcient method to express GPI-anchor
proteins in insect cells. Biochem. Biophys. Res. Commun. 365, 657–
663.
74. Wang, G. (2008) NMR of membrane-associated peptides and
proteins. Curr. Protein Pept. Sci. 9, 50–69.
BI8006324
7000 Biochemistry, Vol. 47, No. 27, 2008 Current Topics